Litcius/Paper detail

Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform

Xiao Xu, Limei Xu, Caining Wen, Jiang Xia, Yuanmin Zhang, Yujie Liang

2023Materials Today Bio95 citationsDOIOpen Access PDF

Abstract

Exosomes have emerged as a promising cell-free therapeutic approach. However, challenges in large-scale production, quality control, and heterogeneity must be overcome before they can be used clinically. Biomimetic exosomes containing key components of natural exosomes have been assembled through extrusion, artificial synthesis, and liposome fusion to address these limitations. These exosome-mimetics (EMs) possess similar morphology and function but provide higher yields, faster large-scale production, and similar size compared to conventional exosomes. This article provides an overview of the chemical and biological properties of various synthetic exosome systems, including nanovesicles (NVs), EMs, and hybrid exosomes. We highlight recent advances in the production and applications of nanobiotechnology and discuss the advantages, limitations, and potential clinical applications of programming assembly of exosome mimetics.

Topics & Concepts

MicrovesiclesNanomedicineExosomeNanobiotechnologyNanotechnologyFunction (biology)Computer scienceMaterials scienceChemistrymicroRNABiologyNanoparticleCell biologyGeneBiochemistryExtracellular vesicles in diseaseMicroRNA in disease regulationRNA Interference and Gene Delivery
Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform | Litcius